AVITA Medical, Inc. (RCEL) DCF Valuation

AVITA Medical, Inc. (RCEL) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

AVITA Medical, Inc. (RCEL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (RCEL) DCF Calculator enables you to assess AVITA Medical, Inc. valuation using real-world financial data, offering complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2016		 AY2
2017		 AY3
2019		 AY4
2020		 AY5
2022		 FY1
2023		 FY2
2024		 FY3
2025		 FY4
2026		 FY5
2027
Revenue .7 .8 12.9 8.9 31.4 29.5 27.7 26.0 24.4 22.9
Revenue Growth, % 0 6.31 0 -30.99 0 -6.17 -6.17 -6.17 -6.17 -6.17
EBITDA -7.8 -11.5 -38.0 -25.8 -24.6 -28.2 -26.5 -24.8 -23.3 -21.9
EBITDA, % -1061.34 -1478.04 -295.97 -291.16 -78.26 -95.65 -95.65 -95.65 -95.65 -95.65
Depreciation .1 .1 .0 .3 .9 1.6 1.5 1.4 1.3 1.2
Depreciation, % 11.83 8.4 -0.00000000000485 3.26 2.89 5.28 5.28 5.28 5.28 5.28
EBIT -7.9 -11.6 -38.0 -26.1 -25.5 -28.4 -26.6 -25.0 -23.5 -22.0
EBIT, % -1073.17 -1486.44 -295.97 -294.42 -81.15 -96.23 -96.23 -96.23 -96.23 -96.23
Total Cash 2.4 9.2 66.4 45.8 72.5 29.5 27.7 26.0 24.4 22.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .1 2.2 1.5 3.2
Account Receivables, % 14.41 19.11 17.05 17.05 10.26
Inventories .6 .7 1.0 .7 1.9 11.9 11.2 10.5 9.8 9.2
Inventories, % 87.88 92.02 7.89 7.89 6.17 40.37 40.37 40.37 40.37 40.37
Accounts Payable .6 .2 3.9 2.7 2.7 10.3 9.7 9.1 8.5 8.0
Accounts Payable, % 83.86 21.65 30.38 30.38 8.72 35 35 35 35 35
Capital Expenditure -.3 -.3 -.5 -.5 -.4 -5.2 -4.8 -4.5 -4.3 -4.0
Capital Expenditure, % -36.64 -39.29 -4.14 -5.94 -1.31 -17.46 -17.46 -17.46 -17.46 -17.46
Tax Rate, % -0.13519 -0.13519 -0.13519 -0.13519 -0.13519 -0.13519 -0.13519 -0.13519 -0.13519 -0.13519
EBITAT -7.2 -10.7 -38.0 -26.1 -25.6 -27.5 -25.8 -24.2 -22.7 -21.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.5 -11.5 -37.2 -26.6 -28.0 -34.8 -28.8 -27.0 -25.3 -23.8
WACC, % 11.73 11.73 11.73 11.73 11.73 11.73 11.73 11.73 11.73 11.73
PV UFCF
SUM PV UFCF -103.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -24
Terminal Value -249
Present Terminal Value -143
Enterprise Value -247
Net Debt -16
Equity Value -230
Diluted Shares Outstanding, MM 25
Equity Value Per Share -9.21

What You Will Get

  • Real RCEL Financial Data: Pre-filled with AVITA Medical, Inc.'s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See AVITA Medical, Inc.'s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue projections, operating margins, and research expenditures.
  • Instant DCF Valuation: Automatically computes intrinsic value, net present value (NPV), and other key financial metrics.
  • High-Precision Accuracy: Leverages AVITA Medical’s real-world financial data for credible valuation results.
  • Seamless Scenario Analysis: Easily evaluate various assumptions and assess their impact on outcomes.
  • Efficiency Booster: Streamline the valuation process by avoiding the construction of intricate financial models from the ground up.

How It Works

  • 1. Open the Template: Download and open the Excel file containing AVITA Medical, Inc.'s (RCEL) preloaded data.
  • 2. Edit Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
  • 4. Test Scenarios: Evaluate various forecasts to explore different valuation outcomes.
  • 5. Use with Confidence: Present professional valuation insights to enhance your decision-making.

Why Choose This Calculator for AVITA Medical, Inc. (RCEL)?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your specific analysis needs.
  • Real-Time Feedback: Observe immediate updates to AVITA Medical’s valuation as you modify inputs.
  • Pre-Loaded Data: Comes with AVITA Medical’s actual financials for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling AVITA Medical, Inc. (RCEL) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for AVITA Medical, Inc. (RCEL).
  • Consultants: Deliver professional valuation insights on AVITA Medical, Inc. (RCEL) to clients quickly and accurately.
  • Business Owners: Understand how companies like AVITA Medical, Inc. (RCEL) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to AVITA Medical, Inc. (RCEL).

What the Template Contains

  • Pre-Filled Data: Includes AVITA Medical's historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze AVITA Medical's profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.